首页> 美国卫生研究院文献>British Journal of Cancer >Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

【2h】

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

机译：尿路上皮膀胱癌患者的尿液EpCAM：表征和生物标志物潜力评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Epithelial cell adhesion molecule is overexpressed in bladder tumours and released from bladder cancer cells in vitro. We test the hypotheses that urinary EpCAM could act as a biomarker for primary bladder cancer detection and risk stratification.

机译：背景：上皮细胞粘附分子在膀胱肿瘤中过度表达，并在体外从膀胱癌细胞中释放出来。我们检验了尿液EpCAM可以作为原发性膀胱癌检测和危险分层的生物标志物的假设。

著录项

期刊名称 British Journal of Cancer
作者
R T Bryan; N J Shimwell; W Wei; A J Devall; S J Pirrie; N D James; M P Zeegers; K K Cheng; A Martin; D G Ward;
展开▼
作者单位

展开▼
年(卷),期 2014(110),3
年度 2014
页码 679–685
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
EpCAM bladder cancer urine biomarker prognosis;

机译：EpCAM;膀胱癌;尿液;生物标志物;预后;

相似文献

外文文献
中文文献
专利

1. Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential [J] . R T Bryan, N J Shimwell, W Wei, British Journal of Cancer . 2014,第3期

机译：尿路上皮膀胱癌患者的尿液EpCAM：表征和生物标志物潜力评估
2. TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients With Urothelial Bladder Cancer [J] . Kun Wang, Tiantian Liu, Cheng Liu, The oncologist . 2015,第3期

机译：TERT启动子突变和TERT mRNA但不是FGFR3突变是中国汉族人尿道膀胱癌患者的尿液生物标志物
3. Regular article Biomarkers, genomics, proteomics, and gene regulation Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder [J] . Stefan Garczyk, Nadina Ortiz-Brüchle, Ursula Schneider, The American journal of pathology. . 2020,第2期

机译：常规文章生物标志物，基因组学，蛋白质组学和基因调节下一代测序揭示了潜在的预测生物标志物和尿液癌的尿路上皮癌治疗靶标
4. 4-aminobiphenyl DNA adducts of urothelial cells from smokers as biomarkers of bladder cancer risk: optimization of sample preparation and nanoLC-ESI-MS/MS. [C] . Joshua J Klaene, Samantha J Sokup, Kaila Norton, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：4-氨基双苯基DNA加入吸烟者作为膀胱癌风险的生物标志物的尿液细胞：样品制备和Nanolc-ESI-MS / MS的优化。
5. Cystoscopy and the development of invasive bladder cancer in patients presenting with superficial urinary bladder cancer. [D] . Amos, Charles E., Jr. 2003

机译：膀胱镜检查和浅表性膀胱癌患者的浸润性膀胱癌的发展。
6. TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients With Urothelial Bladder Cancer [O] . Kun Wang, Tiantian Liu, Cheng Liu, 2015

机译：TERT启动子突变和TERT mRNA但不是FGFR3突变是中国汉族人膀胱膀胱癌患者的尿液生物标志物
7. Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential. [O] . Bryan, R.T., Shimwell, N. J., Wei, W., 2014

机译：尿路上皮膀胱癌患者的尿液EpCAM：生物标志物潜力的表征和评估。

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

摘要

著录项

相似文献

相关主题

期刊订阅